Next Generation Sequencing (NGS) Market Poised to Hit $42.25 Billion by 2033: Key Drivers Behind the Surge - Latest Study by Grand View Research, Inc.
Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer, ...
Simple, Accurate, Affordable Solution for Pharmacogenomics Profiling to Identify Genetic Biomarkers Associated with Drug Response-- --Learn ...
The server room for the Food and Drug Administration’s “Hive” literally buzzes with activity as it harnesses massive amounts of computing power to analyze detailed information on DNA and RNA sequences ...
Delve Bio, a pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, today announced presentations demonstrating the clinical impact of using its flagship metagenomic ...
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company ™, and several distinguished researchers will be ...
SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology ...
Zacks Investment Research on MSN
TEM Continues to Strengthen Its Genomics Leadership With New Products
Tempus AI TEM has been putting in efforts to solidify its position in the genomics space. In September 2025, the company received FDA 510(k) clearance for its xR IVD to support life sciences drug ...
Whole genome analysis plays a critical role in the development of life-saving diagnostics, therapeutics, and vaccines, with growing interest in noncoding regions and Whole genome analysis plays a ...
Antibiotic resistance is quietly spreading worldwide. According to the World Health Organization's (WHO) latest Global ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback